Abstract
Anaphylatoxins C5a and C3a and their des Arg derivatives inhibited C2 production by mononuclear phagocytes. C5a and C5adesArg which were approximately equipotent (IC50 = 10(-10) mol/l) were more effective than C3a (IC50 = 5 X 10(-8) mol/l) which was approximately 10-20-fold more potent than C3adesArg IC50 = 5 X 10(-6) mol/l). Inhibition of C2 production was only reversed slightly by the addition of either indomethacin or ETYA to the cultures. Intracellular levels of cAMP, were increased by anaphylatoxins. The level of cAMP showed a good inverse correlation with C2 levels in the culture supernatants. The data suggest that the reduction in C2 production produced by anaphylatoxins may be mediated by an increase in intracellular cAMP.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Damerau B., Grünefeld E., Vogt W. Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides. Int Arch Allergy Appl Immunol. 1980;63(2):159–169. doi: 10.1159/000232622. [DOI] [PubMed] [Google Scholar]
- Damerau B., Zimmermann B., Grünefeld E., Czorniak K., Vogt W. Biological activities of C5a and C5adesArg from hog serum. Int Arch Allergy Appl Immunol. 1980;63(4):408–414. doi: 10.1159/000232656. [DOI] [PubMed] [Google Scholar]
- Einstein L. P., Schneeberger E. E., Colten H. R. Synthesis of the second component of complement by long-term primary cultures of human monocytes. J Exp Med. 1976 Jan 1;143(1):114–126. doi: 10.1084/jem.143.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goodman M. G., Weigle W. O., Hugli T. E. Inability of the C3a anaphylatoxin to promote cellular lysis. Nature. 1980 Jan 3;283(5742):78–80. doi: 10.1038/283078a0. [DOI] [PubMed] [Google Scholar]
- Harper J. F., Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975;1(4):207–218. [PubMed] [Google Scholar]
- Hugli T. E., Müller-Eberhard H. J. Anaphylatoxins: C3a and C5a. Adv Immunol. 1978;26:1–53. doi: 10.1016/s0065-2776(08)60228-x. [DOI] [PubMed] [Google Scholar]
- Lappin D., Whaley K. Cyclic AMP mediated modulation of complement protein production. Int J Immunopharmacol. 1982;4(5):415–421. doi: 10.1016/0192-0561(82)90015-7. [DOI] [PubMed] [Google Scholar]
- Lappin D., Whaley K. Cyclic AMP-mediated modulation of the production of the second component of human complement by monocytes. Int Arch Allergy Appl Immunol. 1981;65(1):85–90. doi: 10.1159/000232742. [DOI] [PubMed] [Google Scholar]
- McCarthy K., Henson P. M. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg. J Immunol. 1979 Dec;123(6):2511–2517. [PubMed] [Google Scholar]
- Werkmeister J., Zaunders J., McCarthy W., Hersey P. Characterization of an inhibitor of cell division released in tumour cell cultures. Clin Exp Immunol. 1980 Sep;41(3):487–496. [PMC free article] [PubMed] [Google Scholar]
- Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med. 1980 Mar 1;151(3):501–516. doi: 10.1084/jem.151.3.501. [DOI] [PMC free article] [PubMed] [Google Scholar]